Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Ascentage, Ascletis, Astellas, Astrazeneca, Biovaxys Technology, Direct Biologics, Gtreebnt, Humanigen, Kyowa Kirin, Levena, Mabpharm, Moderna, Oblato, Organicell Regenerative Medicine, Rarestone, Regeneron, Sanofi, Sinovac, Sorrento, Swedish Orphan Biovitrum, Yisheng.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cytrellis, Lifesignals, Luxsonic.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aadi, Abbvie, Alexion, Astrazeneca, Beigene, Beximco, Eledon, Fidia, GSK, Incyte, Inhibikase, Iterum, Kyowa Kirin, Neoimmunetech, Otsuka, Polarityte, Saniona.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Evren.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Moderna, Rhythm.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Antares, Ascletis, Biovaxys, Erytech, Index, GBT, Humanigen, Merck & Co., Pfizer, Radius, Rational Vaccines, Sorrento.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Anchordx, Congenica, Innovative Health Sciences, Omniscient Neurotechnology, Philips, Synapse Biomedical, Zoll Medical.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Albireo, Ascentage, Astellas, Bluebird, Direct, Genentech, Inozyme, Magenta, Merck & Co., Organicell, Rarestone, Viracta.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aldeyra, Ardelyx, Ionctura, Keiferx, Myovant, Octapharma, Sanofi, Swedish Orphan.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: AB Science, Akeso, Antengene, Arca, Astellas, Bharat Biotech International, Canbridge, Fibrogen, Hutchmed, Immunitybio, Innovent Biologics, Inotrem, Kintor, Ocugen, Qualigen, RDIF, Seagen, Tevogen.